FDA to Study Hydroxychloroquine for COVID-19
]]>(MedPage Today) -- WASHINGTON--The FDA is carefully considering the malaria and rheumatology drug hydroxychloroquine (Plaquenil) as a treatment for COVID-19, FDA Commissioner Stephen Hahn, MD, said Thursday.Hydroxychloroquine is among several...
Read more »